Regeneron Pharmaceuticals (REGN)

Net Debt

-$469.20M

Quarterly · Period ending: · USD

REGN logo

REGN Net Debt

Latest reported-$469.20M
REGN Quarterly Net Debt (-$21.80M → -$469.20M)
High-resolution chart · PNG

REGN net debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Net Debt — Quarterly (USD)
Period endingNet Debt (USD)
-469,200,000
-256,400,000
-412,200,000
199,100,000
709,300,000
-385,400,000
216,200,000
692,200,000
782,900,000
101,300,000
-27,100,000
550,300,000
765,000,000
-1,214,500,000
-404,500,000
-790,200,000
-694,400,000
-645,300,000
-185,900,000
-733,800,000
625,400,000
1,258,800,000
502,000,000
1,121,800,000
223,700,000
-1,493,000,000
-903,900,000
-672,100,000
-334,200,000
-998,600,000
-759,200,000
-380,640,000
-211,973,000
-314,846,000
-109,280,000
-89,748,000
-43,140,000
-104,166,000
-54,077,000
-538,131,000
-284,985,000
-241,984,000
-433,592,000
-259,720,000
-2,507,000
-35,431,000
-189,655,000
-81,240,000
-82,289,000
69,255,000
-30,096,000
218,964,000
91,627,000
282,386,000
227,052,000
332,737,000
274,289,000
46,248,000
-48,077,000
-45,993,000
-93,978,000
24,775,000
47,458,000
-166,270,000
45,807,000
39,588,000
-98,053,000
-187,750,000
-208,541,000
-199,097,000
-242,703,000
-197,181,000
-173,476,000
-320,875,000
-296,633,000
102,584,000
90,357,000
43,516,000
-37,876,000
32,338,000
85,040,000
17,668,000
15,492,000
23,907,000
54,799,000
52,184,000
98,766,000
94,953,000
77,167,000
25,966,000
95,532,000
-89,321,000
75,488,000
8,475,000
120,073,000
124,663,000
130,950,000
64,996,000
-46,817,000
-97,805,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.